Priyankara Dilshan, Ruwanpathirana Pramith, Rambukwella Roshan, Perera Nilanka
Medical Intensive Care Unit, National Hospital of Sri Lanka, Colombo, Sri Lanka.
Professorial Unit in Medicine, National Hospital of Sri Lanka, Colombo, Sri Lanka.
Trop Med Health. 2024 Dec 19;52(1):96. doi: 10.1186/s41182-024-00665-6.
Leptospirosis, a spirochaete infection, can lead to Leptospirosis Pulmonary Haemorrhage Syndrome (LPHS), which requires intensive care admission and has a high mortality. Although data on short-term outcomes are available, the long-term respiratory sequelae of LPHS survivors are not known. We aimed to identify the post-discharge pulmonary functions and functional limitations in survivors of LPHS.
We conducted a prospective cohort study from January to December 2022 at the Medical Intensive Care Unit (ICU) of the National Hospital of Sri Lanka to assess the sequential changes in the spirometry parameters in patients who survived LPHS. The Forced Vital Capacity (FVC) and Forced Expiratory Volume in 1 s (FEV1) were measured on the day of discharge from the ICU (D0), 7th day after discharge (D7) and 28th day after discharge (D28). The predicted lung volume was calculated using the gender, age and height as per standard protocol. Physical and functional role limitations were assessed on D28 using the modified Medical Outcomes Study Questionnaire Short Form 36 Health Survey (SF-36).
Twenty-one patients with a mean age of 44 years (SD 16.07) were enrolled for the study. The majority were male patients (n = 19, 90.5%). Leptospirosis was serologically confirmed in all individuals. Seventeen (81%) patients had reduced FEV1 and FVC on D0, indicating a restrictive lung abnormality. FVC and FEV1 improved during the first 7 days (p < 0.01) but did not change significantly afterwards. Only seven individuals (33.3%) achieved a normal FVC (exceeding 80% of the predicted volume) at D28. However, 19 (90.5%) individuals achieved a normal FEV1 (exceeding 80% of predicted volume) by D28. In our study, administering corticosteroids during ICU stay did not impact lung recovery in FVC (p = 0.521) or FEV1 (p = 0.798). The participants did not have significant physical, functional, and role limitations at D28.
The spirometry measurements of individuals diagnosed with LPHS significantly improved during the first 7 days. Most survivors did not have a functional impairment despite the FVC not recovering to normal by D28.
钩端螺旋体病是一种螺旋体感染,可导致钩端螺旋体病肺出血综合征(LPHS),该综合征需要入住重症监护病房,且死亡率很高。尽管有关于短期结局的数据,但LPHS幸存者的长期呼吸后遗症尚不清楚。我们旨在确定LPHS幸存者出院后的肺功能和功能受限情况。
2022年1月至12月,我们在斯里兰卡国立医院的医学重症监护病房(ICU)进行了一项前瞻性队列研究,以评估LPHS存活患者肺活量测定参数的连续变化。在从ICU出院当天(D0)、出院后第7天(D7)和出院后第28天(D28)测量用力肺活量(FVC)和第1秒用力呼气量(FEV1)。根据标准方案,使用性别、年龄和身高计算预测肺容积。在D28使用改良的医学结局研究问卷简表36健康调查(SF-36)评估身体和功能角色受限情况。
21名平均年龄为44岁(标准差16.07)的患者纳入研究。大多数为男性患者(n = 19,90.5%)。所有个体均经血清学确诊为钩端螺旋体病。17名(81%)患者在D0时FEV1和FVC降低,表明存在限制性肺异常。FVC和FEV1在最初7天内有所改善(p < 0.01),但此后无显著变化。在D28时,只有7名个体(33.3%)的FVC恢复正常(超过预测容积的80%)。然而,到D28时,19名(90.5%)个体的FEV1恢复正常(超过预测容积的80%)。在我们的研究中,在ICU住院期间使用皮质类固醇对FVC(p = 0.521)或FEV1(p = 0.798)的肺恢复没有影响。参与者在D28时没有明显的身体、功能和角色受限情况。
被诊断为LPHS的个体的肺活量测定值在最初7天内显著改善。尽管到D28时FVC未恢复正常,但大多数幸存者没有功能障碍。